文献速递其他结缔组织病

系统性硬化症中的钙质沉着:发病机制、相关并发症与管理的更新——仍压在患者手上的沉重负担

Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients' hands.
PubMed 文献 · Semin Arthritis Rheum · 2024-03-16

本文综述系统性硬化症(SSc)中营养不良性钙质沉着的发病机制、相关并发症与管理现状。钙质沉着以不溶性钙盐沉积为主,化学形式主要为羟基磷灰石钙,可致压迫性神经病变和严重疼痛,组织缺血和反复创伤可能参与其发生。X线或超声常用于检测,X线与双能CT定量可能有助于评估疾病负担和监测;目前尚无获批的改善病情治疗,合并感染、压迫症状或需缓解疼痛时可能首选减容或手术干预。

要点

  • SSc钙质沉着以不溶性钙盐沉积为特征,化学形式主要为羟基磷灰石钙。
  • 钙质沉着可导致压迫性神经病变和严重疼痛。
  • 目前尚无获批的SSc钙质沉着改善病情治疗,合并感染、压迫症状或需缓解疼痛时可能首选减容或手术干预。

核心结论

  • 尽管钙质沉着在SSc中常见且有临床后果,目前尚无获批的改善病情治疗。
  • 迫切需要创新研究和量身定制的治疗方法以减轻SSc患者的钙质沉着负担。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • SSc中营养不良性钙质沉着是主要临床表现之一,特征为不溶性钙盐沉积于组织,化学形式主要为羟基磷灰石钙。
  • 钙质沉着可能导致压迫性神经病变和严重疼痛。
  • 当前证据提示组织缺血和反复创伤与钙质沉着发生相关,但仍有太多未知领域需要研究。
  • 钙质沉着检测常用X线或超声,X线与双能CT定量可能有助于评估疾病负担和监测疾病。
  • 合并感染、压迫症状或需缓解疼痛的钙质沉着可能首选减容或手术干预。

关键数值与推荐

  • 原文未报告具体标准与数值。

临床怎么用

  • 合并感染、压迫症状或需缓解疼痛的钙质沉着可能首选减容或手术干预。
  • X线与双能CT定量可能有助于评估疾病负担和监测疾病。

局限性

  • 当前证据仍有许多未知领域需要研究。
  • 目前尚无获批的SSc钙质沉着改善病情治疗。
  • 迫切需要创新研究和量身定制的治疗方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In SSc, dystrophic calcinosis is one of the major clinical manifestations, characterized by the deposition of insoluble calcific substances in tissues, predominantly in the chemical form of calcium hydroxyapatite. Furthermore, calcinosis might lead to compressive neuropathies and severe pain. Current evidence suggests that tissue ischemia and repeated trauma are implicated in the development of calcinosis; however, there are still too many unknown areas that need to be investigated. Detection of calcinosis is commonly performed using X-ray or ultrasound. Moreover, quantification of calcinosis with X-ray and dual-energy computed tomography might be useful for the assessment of disease burden and monitoring of the disease. Despite its prevalence and clinical outcomes, there are no approved disease-modifying treatments for calcinosis in SSc. Debulking or surgical intervention might be preferred for calcinosis complicated with infection, compressive symptoms, or relief of pain. Therefore, innovative investigations and tailored therapeutic approaches are urgently needed to lift the burden of calcinosis from the hands of SSc patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Avanoglu-Guler A, Campochiaro C, De Luca G, et al. Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients' hands. Semin Arthritis Rheum. 2024. PMID: 38537324. doi:10.1016/j.semarthrit.2024.152431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。